Oba J - Search Results

1

The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.

Ito T, Moroi Y, Oba J, Nakahara T, Takeuchi S, Uchi H, Takahara M, Masuda T, Furue M. Ito T, et al. Among authors: oba j. Melanoma Res. 2012 Feb;22(1):38-44. doi: 10.1097/CMR.0b013e32834dcfdf. Melanoma Res. 2012. PMID: 22108607

2

Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma: an immunohistochemical study and analysis of prognostic value.

Oba J, Nakahara T, Abe T, Hagihara A, Moroi Y, Furue M. Oba J, et al. J Dermatol Sci. 2011 May;62(2):116-23. doi: 10.1016/j.jdermsci.2011.02.011. Epub 2011 Mar 5. J Dermatol Sci. 2011. PMID: 21454057

3

Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma.

Oba J, Nakahara T, Hayashida S, Kido M, Xie L, Takahara M, Uchi H, Miyazaki S, Abe T, Hagihara A, Moroi Y, Furue M. Oba J, et al. J Am Acad Dermatol. 2011 Dec;65(6):1152-60. doi: 10.1016/j.jaad.2010.10.019. Epub 2011 Jun 23. J Am Acad Dermatol. 2011. PMID: 21700362

4

Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.

Chen H, Takahara M, Oba J, Xie L, Chiba T, Takeuchi S, Tu Y, Nakahara T, Uchi H, Moroi Y, Furue M. Chen H, et al. Among authors: oba j. J Dermatol Sci. 2011 Oct;64(1):39-44. doi: 10.1016/j.jdermsci.2011.06.007. Epub 2011 Jun 23. J Dermatol Sci. 2011. PMID: 21767935

5

CD10-bearing fibroblasts may inhibit skin inflammation by down-modulating substance P.

Xie L, Takahara M, Nakahara T, Oba J, Uchi H, Takeuchi S, Moroi Y, Furue M. Xie L, et al. Among authors: oba j. Arch Dermatol Res. 2011 Jan;303(1):49-55. doi: 10.1007/s00403-010-1093-9. Epub 2010 Nov 13. Arch Dermatol Res. 2011. PMID: 21076839

6

CD10 expressed by fibroblasts and melanoma cells degrades endothelin-1 secreted by human keratinocytes.

Xie L, Moroi Y, Takahara M, Tsuji G, Oba J, Hayashida S, Takeuchi S, Shan B, Uchi H, Furue M. Xie L, et al. Among authors: oba j. Eur J Dermatol. 2011 Jul-Aug;21(4):505-9. doi: 10.1684/ejd.2011.1371. Eur J Dermatol. 2011. PMID: 21616752

7

Expression of programmed death receptor ligand 1 in melanoma may indicate tumor progression and poor patient survival.

Oba J, Nakahara T, Abe T, Hagihara A, Moroi Y, Furue M. Oba J, et al. J Am Acad Dermatol. 2014 May;70(5):954-6. doi: 10.1016/j.jaad.2014.01.880. J Am Acad Dermatol. 2014. PMID: 24742844 No abstract available.

8

Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression.

Nakahara T, Oba J, Shimomura C, Kido-Nakahara M, Furue M. Nakahara T, et al. Among authors: oba j. J Invest Dermatol. 2016 Jan;136(1):146-53. doi: 10.1038/JID.2015.359. J Invest Dermatol. 2016. PMID: 26763434 Free article.

9

Expression of milk fat globule epidermal growth factor-VIII may be an indicator of poor prognosis in malignant melanoma.

Oba J, Moroi Y, Nakahara T, Abe T, Hagihara A, Furue M. Oba J, et al. Br J Dermatol. 2011 Sep;165(3):506-12. doi: 10.1111/j.1365-2133.2011.10409.x. Epub 2011 Jul 28. Br J Dermatol. 2011. PMID: 21574974

10

CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis.

Oba J, Nakahara T, Hashimoto-Hachiya A, Liu M, Abe T, Hagihara A, Yokomizo T, Furue M. Oba J, et al. PLoS One. 2016 Feb 16;11(2):e0149285. doi: 10.1371/journal.pone.0149285. eCollection 2016. PLoS One. 2016. PMID: 26881775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters